Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

CMG Pharmaceutical Co stock

058820.KQ
KR7058820002

Price

2,180.00 KRW
Today +/-
-0.01 KRW
Today %
-0.69 %
P

CMG Pharmaceutical Co stock price

KRW
%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the CMG Pharmaceutical Co stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the CMG Pharmaceutical Co stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the CMG Pharmaceutical Co stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze CMG Pharmaceutical Co's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

CMG Pharmaceutical Co Stock Price History

DateCMG Pharmaceutical Co Price
9/30/20242,180.00 KRW
9/27/20242,195.00 KRW
9/26/20242,180.00 KRW
9/25/20242,180.00 KRW
9/24/20242,215.00 KRW
9/23/20242,200.00 KRW
9/20/20242,200.00 KRW
9/19/20242,205.00 KRW
9/13/20242,145.00 KRW
9/12/20242,115.00 KRW
9/11/20242,050.00 KRW
9/10/20242,095.00 KRW
9/9/20242,075.00 KRW
9/6/20242,080.00 KRW
9/5/20242,120.00 KRW
9/4/20242,175.00 KRW
9/3/20242,250.00 KRW

CMG Pharmaceutical Co Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into CMG Pharmaceutical Co, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by CMG Pharmaceutical Co from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects CMG Pharmaceutical Co’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of CMG Pharmaceutical Co. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into CMG Pharmaceutical Co’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing CMG Pharmaceutical Co’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on CMG Pharmaceutical Co’s growth potential.

CMG Pharmaceutical Co Revenue, EBIT and net profit per share

DateCMG Pharmaceutical Co RevenueCMG Pharmaceutical Co EBITCMG Pharmaceutical Co Net Income
202393.91 B KRW3.04 B KRW6.46 B KRW
202282.2 B KRW2.98 B KRW-388.14 M KRW
202169.48 B KRW1.66 B KRW3.17 B KRW
202064.46 B KRW1.82 B KRW215 M KRW
201958.62 B KRW2.6 B KRW3.05 B KRW
201849.87 B KRW2.57 B KRW6.07 B KRW
201741.54 B KRW1.56 B KRW2.84 B KRW
201632.97 B KRW1.73 B KRW1.73 B KRW
201527.04 B KRW-2.57 B KRW-3.65 B KRW
201422.75 B KRW442 M KRW158 M KRW
201320.4 B KRW791 M KRW296 M KRW
201216.01 B KRW-3.15 B KRW-6.66 B KRW
201117.75 B KRW624 M KRW-1.51 B KRW
201011.35 B KRW-6.74 B KRW-6.95 B KRW
200910.15 B KRW-8.65 B KRW-18.18 B KRW
200810.81 B KRW-4.12 B KRW-5 B KRW
20071.8 B KRW-1.33 B KRW-890 M KRW
20063.33 B KRW-1.18 B KRW-3.41 B KRW
20054.19 B KRW-2 B KRW-2.56 B KRW
200413.08 B KRW-2.84 B KRW-3.87 B KRW

CMG Pharmaceutical Co Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B KRW)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (B KRW)EBIT (B KRW)EBIT MARGIN (%)NET INCOME (B KRW)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
20012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
15.8226.3917.3913.084.193.331.810.8110.1511.3517.7516.0120.422.7527.0432.9741.5449.8758.6264.4669.4882.293.91
-66.81-34.12-24.76-68.01-20.57-45.98501.78-6.1211.8656.41-9.8227.4411.5218.8521.9225.9820.0517.569.967.7818.3114.25
5.54-10.120.70-14.51-26.713.7317.4836.6024.3327.6041.8328.8738.7037.0736.2540.3643.4345.6049.3448.4248.1549.7646.54
0.88-2.670.12-1.9-1.120.120.313.962.473.137.434.627.98.449.813.3118.0422.7428.9231.2133.4540.943.7
0.27-3.82-0.91-2.84-2-1.18-1.33-4.12-8.65-6.740.62-3.150.790.44-2.571.731.562.572.61.821.662.983.04
1.70-14.46-5.26-21.69-47.66-35.58-74.28-38.13-85.25-59.373.52-19.673.881.94-9.515.253.755.154.442.832.393.633.23
0.11-2.260.11-3.87-2.56-3.41-0.89-5-18.18-6.95-1.51-6.660.30.16-3.651.732.846.073.050.223.17-0.396.46
--2,150.00-104.88-3,620.91-33.9533.35-73.91461.24263.90-61.79-78.29341.64-104.44-46.62-2,410.13-147.3464.06113.93-49.69-92.951,372.09-112.26-1,763.66
888810111416182750568310010198117117122139138.89138.89144.22
-----------------------
Details

Keystats

ⓘ

Revenue and Growth

The CMG Pharmaceutical Co Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the CMG Pharmaceutical Co is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (B KRW)RECEIVABLES (B KRW)OTHER REC. (B KRW)INVENTORIES (B KRW)OTHER CURRENT LIAB. (B KRW)CURRENT ASSETS (B KRW)TANGIBLE ASSETS (B KRW)LONG-T. INVEST. (B KRW)LONG-T. REC. (B KRW)INTANGIBLE ASSETS (B KRW)GOODWILL (B KRW)OTHER NON-CURRENT ASSETS (B KRW)NON-CURRENT ASSETS (B KRW)TOTAL ASSETS (B KRW)LIABILITIESCOMMON STOCK (B KRW)ADDITIONAL PAID-IN CAPITAL (B KRW)RETAINED EARNINGS (B KRW)OTHER EQUITY (B KRW)UNREAL. GAINS/LOSSES (M KRW)EQUITY (B KRW)LIABILITIES (B KRW)PROVISIONS (B KRW)OTHER SHORT-TERM LIAB. (B KRW)SHORT-TERM DEBTS (B KRW)LONG-TERM DEBT PORTION (B KRW)SHORT-TERM REC. (B KRW)LONG-T. LIAB. (B KRW)DEFERRED TAXES (M KRW)OTHER LIAB. (B KRW)LONG-T. LIABILITIES (B KRW)DEBT (B KRW)TOTAL CAPITAL (B KRW)
20012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
                                             
1.830.60.380.012.112.855.516.361.562.461.1634.6721.718.837.5759.1657.0554.46119.57109.7890.3477.8168.83
0.010.030.070.030.282.42.247.414.365.558.938.7511.0713.4912.3512.5815.3117.5820.6319.0219.6522.4724.14
0.40.740.540.090.790.070.851.131.0421.670.690.420.340.310.180.360.130.581.511.3712.240.5
14.058.447.453.450.2200.311.712.432.782.742.964.624.915.466.397.918.579.0515.0513.221.2720.57
0.060.070.090.310.050.080.040.110.430.250.840.040.390.740.580.460.60.630.750.630.931.281.71
16.369.878.533.893.455.48.9516.739.8313.0415.3447.1138.2128.326.2778.7781.2381.37150.58145.98125.48135.07115.74
3.793.120.640.484.012.267.1311.110.1610.329.719.3110.8118.8317.8216.9116.1817.2724.1229.7430.5237.4750.71
0.230.330.01000.822.262.50.610.610.50.290.250.20.21.34.154.6645.1621.1522.9952.56
00.680.670.590.5300.050.050000000000007.080.110.08
0.330.270.060.090.1600.150.191.732.591.40.166.3610.311.7713.557.68.0711.0812.0612.7114.3917.3
00000000.310.2300000000000002.27
0.21.131.140.130.131.553.543.690.270.220.350.250.290.440.470.450.413.012.462.412.243.233.43
4.555.532.531.294.834.6313.1217.8313.0113.7411.961017.729.7730.2632.2128.3433.0141.6649.3873.6978.19126.36
20.9115.411.065.188.2810.0322.0734.5622.8426.7827.357.1155.9158.0756.53110.98109.57114.38192.24195.36199.17213.26242.1
                                             
4.94.94.94.96.62.466.337.828.2920.5921.8533.0143.3143.3144.1554.3554.4454.4469.4569.4569.4569.4569.45
3.783.783.783.785.516.7127.3835.7438.4841.5641.3650.9657.6858.0859.07101.2946.947.23105.66106.05104.83104.64104.64
0.11-2.14-2.25-6.12-8.68-12.09-12.98-18.26-37.3643.71-45.16-52.38-52.2-52.39-56.41-54.55-3.42.315.065.648.79914.22
000000000-87.41000.2000.0100001.241.231.29
000000000-35-13-1-1-1-100000402.55632.05632.05
8.796.546.432.563.427.0920.7325.39.4118.418.0331.59494946.81101.1197.94103.98180.16181.13184.7184.95190.23
0.640.261.050.040.011.060.321.71.581.491.482.673.914.724.845.6974.164.335.595.0411.249.2
0.210.880.2412.86000.431.50.410.360.480.450.531.250.671.911.382.052.032.123.183.57
0.180.070.090.030.671.921.050.810.961.831.661.411.141.932.752.781.972.962.795.616.167.1210.68
10.587.453.221.530000500000.010.0100000000.88
00000.08000.030.011.584.132.2301.5400000.130.420.410.360.21
11.68.654.62.63.622.971.372.979.055.327.636.795.58.728.859.1410.888.59.3113.6513.7321.924.53
00001.23005.753.362001.42000000.160.070.16.3625.03
00000000000000000000000
0.520.220.030.020.02001.081.021.051.6418.7200.350.880.740.741.92.620.510.650.052.3
0.520.220.030.021.24006.834.373.051.6418.721.420.350.880.740.741.92.780.580.746.427.34
12.128.874.632.624.862.971.379.813.428.379.2725.526.929.079.739.8711.6210.412.0914.2214.4728.3151.87
20.9115.411.065.188.2810.0622.135.122.8426.7827.357.1155.9158.0756.53110.98109.57114.38192.24195.36199.17213.26242.1
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of CMG Pharmaceutical Co provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand CMG Pharmaceutical Co's financial health and stability.

Assets

CMG Pharmaceutical Co's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that CMG Pharmaceutical Co must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of CMG Pharmaceutical Co after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into CMG Pharmaceutical Co's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (B KRW)DEPRECIATION (B KRW)DEFERRED TAXES (B KRW)CHANGES IN WORKING CAPITAL (B KRW)NON-CASH ITEM (B KRW)PAID INTEREST (M KRW)PAID TAXES (M KRW)NET CASH FLOW FROM OPERATING ACTIVITIES (B KRW)CAPITAL EXPENDITURES (M KRW)CASH FLOW FROM INVESTING ACTIVITIES (B KRW)CASH FLOW FROM OTHER INVESTING ACTIVITIES (B KRW)INTEREST INCOME AND EXPENSES (M KRW)NET DEBT CHANGE (B KRW)NET CHANGE IN EQUITY (B KRW)CASH FLOW FROM FINANCING ACTIVITIES (B KRW)CASH FLOW FROM OTHER FINANCING ACTIVITIES (B KRW)TOTAL DIVIDENDS PAID (M KRW)NET CHANGE IN CASH FLOW (B KRW)FREE CASH FLOW (M KRW)SHARE-BASED COMPENSATION (M KRW)
2001200220032004200520062007200820092010201120122013201420152016201720182019202020212022
0.11-2.250.11-3.87-2.56-3.41-0.89-5-18.18-6.95-1.51-6.660.30.16-3.651.692.836.073.050.223.17-0.39
0.220.280.20.190.220.190.050.371.551.241.341.41.121.461.892.11.851.852.112.442.492.28
-0.05-0.970.041.05000000000000000000
-2.334.811.792.672.58-0.64-4.09-5.1-0.73-2.68-4.170.23-6.54-1.720.51-1.92-3.15-5.95-4.2-4.59-0.98-3.55
-0.04-0.33-1.070.070.531.10.273.4411.672.41.773.461.190.823.661.450.41-1.071.864.880.956.59
000000000757172165000000000194
00000000000000-24-3181-51184424107107
-2.11.541.080.120.78-2.76-4.66-6.28-5.68-5.98-2.56-1.57-3.940.722.413.321.950.892.822.945.634.94
-541-432-711-84-3,820-2,430-5,091-3,680-3,756-2,265-375-571-8,988-13,434-3,635-3,127-1,409-3,530-11,650-9,650-3,951-10,307
-0.47-0.73.540.29-5.282.16-9.74-3.35-4.12-2.62-1.77-30.2721.14-13.61-8.67-56.09-0.478.78-70.6-13.01-8.48-10.87
0.07-0.274.250.37-1.464.59-4.650.33-0.37-0.36-1.4-29.6930.12-0.18-5.04-52.970.9412.31-58.95-3.36-4.53-0.56
0000000000000000000000
4.19-3.05-4.31-1.53-0.23-1.23011.22.8621.519.99000000-0.11-0.46-0.485.63
00003.426.9614.261.991.8115.190.9917.3400052.360.17072.99000
4.12-2.31-4.98-0.45.12.8414.2613.154.639.993.0435.36-0.160.01052.360.17072.88-0.46-0.485.63
-0.070.74-0.671.131.92-2.890-0.05-0.03-7.190.55-1.97-0.160.0100000000
0000000000000000000000
1.54-1.47-0.350.010.62.24-0.143.52-5.171.38-1.293.5217.03-12.88-6.26-0.421.659.675.11-10.53-3.29-0.3
-2,640.11,103.5369.332.5-3,045.8-5,192.7-9,751.6-9,963.6-9,439.8-8,249.1-2,935.4-2,143.7-12,927-12,709.6-1,224.3194.2538.8-2,643.8-8,826.6-6,706.21,677.42-5,369.99
0000000000000000000000

CMG Pharmaceutical Co stock margins

The CMG Pharmaceutical Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of CMG Pharmaceutical Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for CMG Pharmaceutical Co.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the CMG Pharmaceutical Co's sales revenue. A higher gross margin percentage indicates that the CMG Pharmaceutical Co retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the CMG Pharmaceutical Co's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the CMG Pharmaceutical Co's total revenue generated. When comparing the revenue margin year over year, investors can gauge the CMG Pharmaceutical Co's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the CMG Pharmaceutical Co. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the CMG Pharmaceutical Co's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

CMG Pharmaceutical Co Margin History

CMG Pharmaceutical Co Gross marginCMG Pharmaceutical Co Profit marginCMG Pharmaceutical Co EBIT marginCMG Pharmaceutical Co Profit margin
202346.54 %3.23 %6.87 %
202249.76 %3.63 %-0.47 %
202148.15 %2.39 %4.56 %
202048.42 %2.83 %0.33 %
201949.34 %4.44 %5.2 %
201845.6 %5.15 %12.16 %
201743.43 %3.75 %6.83 %
201640.36 %5.25 %5.24 %
201536.25 %-9.51 %-13.5 %
201437.07 %1.94 %0.69 %
201338.7 %3.88 %1.45 %
201228.87 %-19.67 %-41.6 %
201141.83 %3.52 %-8.49 %
201027.6 %-59.37 %-61.19 %
200924.33 %-85.25 %-179.14 %
200836.6 %-38.13 %-46.22 %
200717.48 %-74.28 %-49.55 %
20063.73 %-35.58 %-102.59 %
2005-26.71 %-47.66 %-61.11 %
2004-14.51 %-21.69 %-29.6 %

CMG Pharmaceutical Co Stock Sales Revenue, EBIT, Earnings per Share

The CMG Pharmaceutical Co earnings per share therefore indicates how much revenue CMG Pharmaceutical Co has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue CMG Pharmaceutical Co earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates CMG Pharmaceutical Co's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of CMG Pharmaceutical Co’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating CMG Pharmaceutical Co's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

CMG Pharmaceutical Co Revenue, EBIT and net profit per share

DateCMG Pharmaceutical Co Sales per ShareCMG Pharmaceutical Co EBIT per shareCMG Pharmaceutical Co Earnings per Share
2023651.15 KRW21.06 KRW44.76 KRW
2022591.81 KRW21.47 KRW-2.79 KRW
2021500.21 KRW11.96 KRW22.79 KRW
2020463.74 KRW13.11 KRW1.55 KRW
2019480.52 KRW21.34 KRW25.01 KRW
2018426.2 KRW21.95 KRW51.84 KRW
2017355.01 KRW13.32 KRW24.23 KRW
2016336.43 KRW17.66 KRW17.63 KRW
2015267.74 KRW-25.46 KRW-36.14 KRW
2014227.53 KRW4.42 KRW1.58 KRW
2013245.81 KRW9.53 KRW3.57 KRW
2012285.88 KRW-56.23 KRW-118.93 KRW
2011355.04 KRW12.48 KRW-30.16 KRW
2010420.37 KRW-249.59 KRW-257.22 KRW
2009563.72 KRW-480.56 KRW-1,009.83 KRW
2008675.5 KRW-257.56 KRW-312.19 KRW
2007128.29 KRW-95.29 KRW-63.57 KRW
2006302.27 KRW-107.55 KRW-310.09 KRW
2005418.6 KRW-199.5 KRW-255.8 KRW
20041,635.5 KRW-354.75 KRW-484.13 KRW

CMG Pharmaceutical Co business model

CMG Pharmaceutical Co is one of the most popular companies on Eulerpool.com.

CMG Pharmaceutical Co Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

CMG Pharmaceutical Co historical P/E ratio, EBIT multiple, and P/S ratio

CMG Pharmaceutical Co shares outstanding

The number of shares was CMG Pharmaceutical Co in 2023 — This indicates how many shares 144.217 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue CMG Pharmaceutical Co earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates CMG Pharmaceutical Co's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of CMG Pharmaceutical Co’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating CMG Pharmaceutical Co's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

CMG Pharmaceutical Co stock splits

In CMG Pharmaceutical Co's history, there have been no stock splits.
Unfortunately, there are currently no price targets and forecasts available for CMG Pharmaceutical Co.

CMG Pharmaceutical Co shareholders

%
Name
Stocks
Change
Date
25.83774 % Chabiotech Co Ltd35,886,55309/30/2023
2.09977 % The Vanguard Group, Inc.2,916,40837,5173/31/2024
0.55955 % Dimensional Fund Advisors, L.P.777,17302/29/2024
0.36933 % Norges Bank Investment Management (NBIM)512,963-277,33812/31/2023
0.14851 % State Street Global Advisors (US)206,2704,1722/29/2024
0.13265 % Charles Schwab Investment Management, Inc.184,24003/31/2024
0.05982 % Dimensional Fund Advisors, Ltd.83,08302/29/2024
0.00772 % American Century Investment Management, Inc.10,71903/31/2024
0.00649 % Vanguard Global Advisers LLC9,00903/31/2024
0.00616 % CMG Pharmaceutical Co., Ltd Employees8,560-2,7609/30/2023
1
2
3

Most common questions regarding CMG Pharmaceutical Co

What is the P/E ratio of CMG Pharmaceutical Co 2024?

The P/E ratio cannot be calculated for CMG Pharmaceutical Co at the moment.

What is the P/S ratio of CMG Pharmaceutical Co 2024?

The P/S cannot be calculated for CMG Pharmaceutical Co currently.

What is the AlleAktien quality score of CMG Pharmaceutical Co?

The AlleAktien quality score for CMG Pharmaceutical Co is 4/10.

What is the revenue of CMG Pharmaceutical Co 2024?

The revenue cannot currently be calculated for CMG Pharmaceutical Co.

How high is the profit of CMG Pharmaceutical Co 2024?

The profit cannot currently be calculated for CMG Pharmaceutical Co.

What is the business model of CMG Pharmaceutical Co

No history available for CMG Pharmaceutical Co.

What is the CMG Pharmaceutical Co dividend?

CMG Pharmaceutical Co pays a dividend of 0 KRW distributed over payouts per year.

How often does CMG Pharmaceutical Co pay dividends?

The dividend cannot currently be calculated for CMG Pharmaceutical Co or the company does not pay out a dividend.

What is the CMG Pharmaceutical Co ISIN?

The ISIN of CMG Pharmaceutical Co is KR7058820002.

What is the CMG Pharmaceutical Co ticker?

The ticker of CMG Pharmaceutical Co is 058820.KQ.

How much dividend does CMG Pharmaceutical Co pay?

Over the past 12 months, CMG Pharmaceutical Co paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, CMG Pharmaceutical Co is expected to pay a dividend of 0 KRW.

What is the dividend yield of CMG Pharmaceutical Co?

The current dividend yield of CMG Pharmaceutical Co is .

When does CMG Pharmaceutical Co pay dividends?

CMG Pharmaceutical Co pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of CMG Pharmaceutical Co?

CMG Pharmaceutical Co paid dividends every year for the past 0 years.

What is the dividend of CMG Pharmaceutical Co?

For the upcoming 12 months, dividends amounting to 0 KRW are expected. This corresponds to a dividend yield of 0 %.

In which sector is CMG Pharmaceutical Co located?

CMG Pharmaceutical Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von CMG Pharmaceutical Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of CMG Pharmaceutical Co from 10/2/2024 amounting to 0 KRW, you needed to have the stock in your portfolio before the ex-date on 10/2/2024.

When did CMG Pharmaceutical Co pay the last dividend?

The last dividend was paid out on 10/2/2024.

What was the dividend of CMG Pharmaceutical Co in the year 2023?

In the year 2023, CMG Pharmaceutical Co distributed 0 KRW as dividends.

In which currency does CMG Pharmaceutical Co pay out the dividend?

The dividends of CMG Pharmaceutical Co are distributed in KRW.

All fundamentals about CMG Pharmaceutical Co

Our stock analysis for CMG Pharmaceutical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of CMG Pharmaceutical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.